Hormone ablation therapy: lightening the load for today's prostate cancer patient. Urologic nursing : official journal of the American Urological Association Allied [Urol Nurs] Journal article

Title	Hormone ablation therapy: lightening the load for today's prostate cancer patient.
Author(s)	Matthews PA
Institution	Department of Veterans Affairs, Eastern Colorado Health Care System, Denver, CO, USA.
Source	Urol Nurs 2007 Feb.:3-11.
MeSH	Androgen Antagonists Antineoplastic Agents, Hormonal Combined Modality Therapy Drug Monitoring Finasteride Flutamide Gonadotropin-Releasing Hormone Humans Leuprolide Male Mass Screening Neoplasm Staging Nurse's Role Nursing Assessment Oligopeptides Patient Education Prostate-Specific Antigen Prostatectomy Prostatic Neoplasms Quality of Life Testosterone 5-alpha-Reductase Treatment Outcome
Abstract	Prostate cancer is the most common nonskin cancer in the United States, with more than 2 million men currently living with the disease (Prostate Cancer Foundation, 2005). Hormone ablation therapy has resulted in much improved outcomes for thousands of men with this disease; however, there are often side effects that impact patients' quality of life. An overview of the use of hormone ablation therapy and the critical role nurses play for patients undergoing this treatment is provided.
Language	eng
Pub Type(s)	Journal Article Review
PubMed ID	17474637

Advertise on this site.